NCT07206940

Brief Summary

Pleural effusion and pneumothorax are common conditions encountered in pulmonology departments and may require chest drainage. However, the chest drainage procedure can cause anxiety in patients, leading to discomfort during the procedure. The use of virtual reality (VR) for anxiety reduction has shown promising results in various medical contexts.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Nov 2025May 2027

First Submitted

Initial submission to the registry

September 26, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 27, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

September 26, 2025

Last Update Submit

December 24, 2025

Conditions

Keywords

PneumothoraxPleural EffusionDrainagevirtual realityanxiety reduction

Outcome Measures

Primary Outcomes (2)

  • Pain and Effects of personalized virtual reality

    Compare the effects of personalized virtual reality support, compared to standard support, on pain in patients undergoing chest drainage with numerical pain scale from 0 to 10.

    18 months

  • Anxiety and Effects of personalized virtual reality

    Compare the effects of personalized virtual reality support, compared to standard support, on anxiety in patients undergoing chest drainage with numerical anxiety scale from 0 to 10.

    18 months

Secondary Outcomes (4)

  • Pain assessment with or without VR headset based on heart rate

    18 months

  • Pain assessment with or without VR headset based on respiratory rate

    18 months

  • Patient satisfaction

    18 months

  • Satisfaction of the paramedical team

    18 months

Study Arms (2)

Reality virtual

EXPERIMENTAL

Standard support with reality virtual headset

Device: Drainage with Headset Hypno VR

Standard of care

NO INTERVENTION

Standard support without reality virtual headset

Interventions

Pleural effusion and pneumothorax will be drained with the patient wearing the virtual reality headset.

Reality virtual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years;
  • Patient requiring Sledinger thoracic drainage for pneumothorax or pleural effusion in the pulmonology department of Nice University Hospital;
  • Patient affiliated with social security;
  • Signature of informed consent.

You may not qualify if:

  • Immediate emergency situations;
  • Anxiolytic, antidepressant, or psychotropic treatment already in place;
  • Cognitive, behavioral, or psychiatric disorders;
  • Language barrier;
  • History of chest drainage or chest surgery;
  • Hearing disorders without hearing aids;
  • Vision disorders without corrective lenses (lack of binocular vision, blindness);
  • Psychotic patients or patients diagnosed with psychiatric disorders;
  • History of epilepsy;
  • Current migraine;
  • Patients for whom three-dimensional films are contraindicated (pacemaker or defibrillator);
  • No social security coverage;
  • Patients under guardianship/curatorship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Nice - Hôpital Pasteur 2

Nice, Alpes-Maritimes, 06000, France

Location

MeSH Terms

Conditions

PneumothoraxPleural Effusion

Interventions

Drainage

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsSurgical Procedures, Operative

Study Officials

  • Nelly BANSE

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2025

First Posted

October 3, 2025

Study Start

November 27, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

December 31, 2025

Record last verified: 2025-12

Locations